The Protein Structure Initiative, Five Years Later

Five years have passed since the National Institutes of Health launched the Protein Structure Initiative (PSI), a 10-year, $600 million effort to accelerate structural genomics.

Written byJohn Norvell
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Five years have passed since the National Institutes of Health launched the Protein Structure Initiative (PSI), a 10-year, $600 million effort to accelerate structural genomics. The project's pilot phase emphasized technical development and ended earlier this year; the second (production) phase is now underway. Now, $270 million dollars and 1,200 structures later, it is instructive to reflect and see what we have learned.

The mission of the PSI is to make the three-dimensional, atomic-level structures of most proteins easily available from knowledge of their amino acid sequences. At the moment this is impossible: we simply don't know what many protein folds look like. But by systematically determining the structure of an exemplar of each sequence family, we hope to give researchers the resources to overcome this deficit. An added benefit of this effort is the development of tools to accelerate experimental structure prediction, whether by X-ray crystallography or nuclear magnetic ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies